Hergenc, G. Et Al. 2007. Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes. 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , (California, United States Of America).

Hergenc, G., Onat, A., Can, G., Yazici, M., Karabulut, A., & Albayrak, S., (2007). Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes . 59th Annual Meeting of the American-Association-for-Clinical-Chemistry, California, United States Of America

Hergenc, G. Et Al. "Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes," 59th Annual Meeting of the American-Association-for-Clinical-Chemistry, California, United States Of America, 2007

Hergenc, G. Et Al. "Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes." 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , California, United States Of America, 2007

Hergenc, G. Et Al. (2007) . "Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes." 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , California, United States Of America.

@conferencepaper{conferencepaper, author={G. Hergenc Et Al. }, title={Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes}, congress name={59th Annual Meeting of the American-Association-for-Clinical-Chemistry}, city={California}, country={United States Of America}, year={2007}}